Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Journal of Graduate Medical Education
|
August 30, 2018
A Call to Action
John Duval, David Entwistle
Natural Product Reports
|
May 5, 2020
Engineering biosynthetic enzymes for industrial natural product synthesis
Stephanie Galanie, David Entwistle, James Lalonde
JAMA
|
August 7, 2023
Creation and Adoption of Large Language Models in Medicine
Nigam H Shah, David Entwistle, Michael A Pfeffer
Communications Chemistry
|
February 12, 2020
Chemoenzymatic conversion of amides to enantioenriched alcohols in aqueous medium
Jacob E Dander, Maude Giroud, Sophie Racine, et al.
The Journal of Organic Chemistry
|
June 23, 2018
Baeyer-Villiger Monooxygenase-Mediated Synthesis of Esomeprazole As an Alternative for Kagan Sulfoxidation
Yong Koy Bong, Shiwei Song, Jovana Nazor, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
Lyn H Jones, Helen Baldock, Mark E Bunnage, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Journal of Graduate Medical Education
|
August 30, 2018
A Call to Action
John Duval, David Entwistle
Natural Product Reports
|
May 5, 2020
Engineering biosynthetic enzymes for industrial natural product synthesis
Stephanie Galanie, David Entwistle, James Lalonde
JAMA
|
August 7, 2023
Creation and Adoption of Large Language Models in Medicine
Nigam H Shah, David Entwistle, Michael A Pfeffer
Communications Chemistry
|
February 12, 2020
Chemoenzymatic conversion of amides to enantioenriched alcohols in aqueous medium
Jacob E Dander, Maude Giroud, Sophie Racine, et al.
The Journal of Organic Chemistry
|
June 23, 2018
Baeyer-Villiger Monooxygenase-Mediated Synthesis of Esomeprazole As an Alternative for Kagan Sulfoxidation
Yong Koy Bong, Shiwei Song, Jovana Nazor, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
Lyn H Jones, Helen Baldock, Mark E Bunnage, et al.
Page
of 1